TOP STORIES

• REGULATORY “Specified Clinical Research” Data with High Integrity Could Be Used for Drug Review: MHLW Councilor
  May 8, 2017

• REGULATORY MHLW Study Group Drafts “Items to Consider” to Promote Development of Nucleic Acid Drugs
  May 2, 2017

• REGULATORY MHLW Poised to Create Standards for Cancer Treatment in the Elderly
  May 1, 2017

• REGULATORY 2017 Economic and Fiscal Policy Guidelines Likely to Be Tinged with MOF Color
  April 28, 2017

• BUSINESS Astellas Sales Dip 4.4% on Forex Moves, Japan Biz Dented by Price Cuts
  April 28, 2017

• REGULATORY JMA’s Nakagawa Says MHLW Should Fuel Generic Industry Realignment: Chuikyo
  April 27, 2017

• REGULATORY Me-Too Drugs in Jeopardy? CEFP Working Group Pushes Rigid Drug Selection for Innovation Premium
  April 26, 2017

• REGULATORY LDP Health Panel to Compile Resolution on Drug Pricing
  April 25, 2017

• BUSINESS Mundipharma Japan Chief Voices Eagerness on Rare Cancer Therapies
  April 25, 2017

• REGULATORY Sakigake Fast-Track Designation Given to Aducanumab, 4 Other Products
  April 24, 2017

• REGULATORY MOF Calls for Scrapping Price Maintenance Premium
  April 21, 2017

• ORGANIZATION Innovation Premium Top Priority for 3 Trade Groups; EFPIA Ideally Wants Its Expansion
  April 20, 2017

• BUSINESS Xarelto Issue Morally Questionable, but Does Not Constitute Misleading Ads Banned under Law: MHLW Officials
  April 20, 2017

• COMMENTARY Will Government Take the Lead in Pricing Debate towards 2017 Fiscal Blueprint?
  April 19, 2017

• BUSINESS Boehringer Japan Logs 14 Consecutive Years of Growth in Ethical Drug Sales
  April 18, 2017

• REGULATORY With Clinical Research Law Enacted, MHLW Eyes New Panel to Discuss Requirements for “Specified Clinical Research”: R&D Division Head
  April 17, 2017

• INTERVIEW Centerpiece of FPMAJ’s Lobbying Push Will Be Price Maintenance Premium: Chairman
  April 14, 2017

• BUSINESS Takeda Chairman Hasegawa to Retire, Become Adviser in June
  April 14, 2017

• BUSINESS Sales Rep and Doctor at Center of Xarelto Survey Scandal Conflict over “Patient Consent”
  April 14, 2017

• ORGANIZATION PhRMA Chair Repeats Call for Keeping Price Maintenance Premium to Secure Market Predictability
  April 13, 2017

ページ

• « 先頭
• ‹ Prev
• …
• 156
• 157
• 158
• 159
• 160
• 161
• 162
• 163
• 164
• …
• Next ›
• 最終 »